2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
- Svensson, E., van der Walt, J.-S., Barnes, K. I., Cohen, K., Kredo, T., Huitema, A., Nachega, J. B., Karlsson, M. O., & Denti, P. (2012). Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2012.04205.x
- Zvada, S. P., Denti, P., Geldenhuys, H., Meredith, S., van As, D., Hatherill, M., Hanekom, W., Wiesner, L., Simonsson, U. S. H., Jindani, A., Harrison, T., & McIlleron, H. M. (2012). Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high-dose rifapentine. Antimicrobial Agents and Chemotherapy, 56(May), 4471–4473. https://doi.org/10.1128/AAC.00404-12
- Zhang, C., McIlleron, H., Ren, Y., van der Walt, J.-S., Karlsson, M. O., Simonsson, U. S. H., & Denti, P. (2012). Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children. Antiviral Therapy, 17(1), 25–33. https://doi.org/10.3851/IMP1915
- Zhang, C., Denti, P., van der Walt, J.-S., Ren, Y., Smith, P., Karlsson, M. O., & McIlleron, H. (2012). Population Pharmacokinetic Model for Adherence Evaluation Using Lamivudine Concentration Monitoring. Therapeutic Drug Monitoring, 34(4), 1. https://doi.org/10.1097/FTD.0b013e31825c6067
- McIlleron, H., Rustomjee, R., Vahedi, M., Mthiyane, T., Denti, P., Connolly, C., Rida, W., Pym, A., Smith, P. J., & Onyebujoh, P. C. (2012). Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing Guidelines. Antimicrobial Agents and Chemotherapy, 56(6), 3232 LP – 3238. https://doi.org/10.1128/AAC.05526-11